跳至主要内容
临床试验/ISRCTN78768405
ISRCTN78768405已完成不适用

Efficacy and safety of rectal artesunate in paediatric patients - a randomised controlled study (Ghana and Tanzania)

ICEF/UNDP/World Bank/WHO - Special Programme for Research and Training in Tropical Diseases (TDR)0 个研究点目标入组 246 人开始时间: 2005年6月7日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
246

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Aged 3 to 24 months
  • 2. Suspected malaria with no other obvious cause of illness
  • 3. P. falciparum asexual parasitaemia greater than ++ (5 - 10 parasites/High Power Field [HPF])
  • 4. Unable to eat, suck or drink, or repeatedly vomiting (more than three episodes over past 24 hours); or prostrate (unable to sit or stand if previously able to do so)
  • 5. History of convulsions over the preceding 24 hours or impaired consciousness (Blantyre Coma Score less than five)
  • 6. Parent/guardian informed consent

排除标准

  • 1. Ability to tolerate oral intake
  • 2. Acute diarrhoea defined as the presence of more than three episodes of watery stools in the preceding 24 hours
  • 3. History of allergy to artemisinin compounds and/or quinine

研究者

发起方
ICEF/UNDP/World Bank/WHO - Special Programme for Research and Training in Tropical Diseases (TDR)

相似试验